Literature DB >> 7170273

Hypercalcaemia due to immobilization of a patient with Paget's disease of bone.

A W Nathan, H A Ludlam, D W Wilson, P Dandona.   

Abstract

A man with Paget's disease of bone was admitted with a fractured neck of femur. On admission he was normocalcaemic, but with immobilization he rapidly became hypercalcaemic, despite a normal diet and no medication. The hypercalcaemia responded to calcitonin. Although hypercalcaemia is often quoted as complicating the immobilization of such patients, well documented uncomplicated cases have rarely been reported.

Entities:  

Mesh:

Year:  1982        PMID: 7170273      PMCID: PMC2426581          DOI: 10.1136/pgmj.58.685.714

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

Review 1.  PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS.

Authors:  C N DE DEUXCHAISNES; S M KRANE
Journal:  Medicine (Baltimore)       Date:  1964-05       Impact factor: 1.889

2.  Hyperparathyroidism associated with Paget's disease.

Authors:  N N KOHN; R M MYERSON
Journal:  Ann Intern Med       Date:  1961-05       Impact factor: 25.391

3.  Calcitonin treatment of Paget's disease.

Authors:  I M Evans
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

4.  Hypercalcaemia due to immobilisation in Paget's disease of bone.

Authors:  M Fuss; A Bergans; J Corvilain
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

5.  Hypercalcaemia in Paget's disease of bone.

Authors:  W H Auld; R H Simpson; M Smyth
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

  5 in total
  2 in total

1.  Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism.

Authors:  A G Need; H A Morris; M Horowitz; B E Nordin
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

Review 2.  Paget disease: when to treat and when not to treat.

Authors:  Frederick R Singer
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.